Danaher to Acquire Masimo in $9.9 Billion All-Cash Deal

Danaher Corporation has reached an agreement to acquire medical technology firm Masimo for approximately $9.9 billion in an all-cash transaction. The deal, which has received the full endorsement of Masimo's board of directors, marks a significant expansion for Danaher in the healthcare sector. Upon completion, Masimo will be integrated into Danaher's Diagnostics segment, enhancing its portfolio of medical technology solutions. Following the announcement, shares of Masimo experienced a significant surge as investors reacted positively to the acquisition premium. Analysts view the move as a strategic step for Danaher to consolidate its position in the MedTech market. The transaction underscores the ongoing trend of consolidation within the global healthcare and diagnostics industry.